Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The Randomized Phase II ARC-9 Study of Etrumadenant-Based Therapy versus Regorafenib in Patients with Previously Treated Metastatic Colorectal Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 01, 2025
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 26, 2024
Correction to: Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma.
Journal: Investigational new drugs
Published: April 26, 2019
Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma.
Journal: Investigational new drugs
Published: September 29, 2017
Tumor Cell-Free DNA Copy Number Instability Predicts Therapeutic Response to Immunotherapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 25, 2017
A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus).
Journal: British journal of cancer
Published: January 06, 2017
Endoscopic management of a gastrocolonic fistula.
Journal: Gastrointestinal endoscopy
Published: February 07, 2016
Comparing two assays for clinical genomic profiling: the devil is in the data [Letter of clarification].
Journal: OncoTargets and therapy
Published: October 02, 2015
Evaluation and comparison of two commercially available targeted next-generation sequencing platforms to assist oncology decision making.
Journal: OncoTargets and therapy
Published: May 12, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026